Guven DC - Search Results

1

PILE: a candidate prognostic score in cancer patients treated with immunotherapy.

Guven DC, Yildirim HC, Bilgin E, Aktepe OH, Taban H, Sahin TK, Cakir IY, Akin S, Dizdar O, Aksoy S, Yalcin S, Erman M, Kilickap S. Guven DC, et al. Clin Transl Oncol. 2021 Aug;23(8):1630-1636. doi: 10.1007/s12094-021-02560-6. Epub 2021 Feb 14. Clin Transl Oncol. 2021. PMID: 33586122

2

Increased cancer risk in patients with periodontitis.

Dizdar O, Hayran M, Guven DC, Yılmaz TB, Taheri S, Akman AC, Bilgin E, Hüseyin B, Berker E. Dizdar O, et al. Among authors: guven dc. Curr Med Res Opin. 2017 Dec;33(12):2195-2200. doi: 10.1080/03007995.2017.1354829. Epub 2017 Aug 11. Curr Med Res Opin. 2017. PMID: 28699803

3

Fusobacterium and colorectal carcinogenesis.

Güven DC, Dizdar O. Güven DC, et al. Carcinogenesis. 2018 Jan 12;39(1):84. doi: 10.1093/carcin/bgx092. Carcinogenesis. 2018. PMID: 28968715 No abstract available.

4

Cancer incidence in familial Mediterranean fever patients: a retrospective analysis from central Anatolia.

Bilgin E, Dizdar Ö, Güven DC, Ceylan S, Aybi Ö, Fırlatan B, Kardaş RC, Yıldırım T, Hayran MK, Kalyoncu U, Özen S. Bilgin E, et al. Among authors: guven dc. Rheumatol Int. 2019 Jun;39(6):1045-1051. doi: 10.1007/s00296-019-04311-x. Epub 2019 Apr 25. Rheumatol Int. 2019. PMID: 31025139

5

Analysis of Fusobacterium nucleatum and Streptococcus gallolyticus in saliva of colorectal cancer patients.

Guven DC, Dizdar O, Alp A, Akdoğan Kittana FN, Karakoc D, Hamaloglu E, Lacin S, Karakas Y, Kilickap S, Hayran M, Yalcin S. Guven DC, et al. Biomark Med. 2019 Jun;13(9):725-735. doi: 10.2217/bmm-2019-0020. Epub 2019 Jun 3. Biomark Med. 2019. PMID: 31157977

6

Exploiting DNA repair defects in breast cancer: from chemotherapy to immunotherapy.

Aktas BY, Guner G, Guven DC, Arslan C, Dizdar O. Aktas BY, et al. Among authors: guven dc. Expert Rev Anticancer Ther. 2019 Jul;19(7):589-601. doi: 10.1080/14737140.2019.1631162. Epub 2019 Jun 17. Expert Rev Anticancer Ther. 2019. PMID: 31181965 Review.

7

Evaluation of cancer risk in patients with periodontal diseases.

Güven DC, Dizdar Ö, Akman AC, Berker E, Yekedüz E, Ceylan F, Başpınar B, Akbıyık İ, Aktaş BY, Yüce D, Erman M, Hayran M. Güven DC, et al. Turk J Med Sci. 2019 Jun 18;49(3):826-831. doi: 10.3906/sag-1812-8. Turk J Med Sci. 2019. PMID: 31195790 Free PMC article.

8

Complete responses to two different anti-PD1 agents in a metastatic melanoma patient.

Kilickap S, Guven DC, Aktepe OH, Aktas BY, Dizdar O. Kilickap S, et al. Among authors: guven dc. J Oncol Pharm Pract. 2020 Mar;26(2):496-499. doi: 10.1177/1078155219858657. Epub 2019 Jun 29. J Oncol Pharm Pract. 2020. PMID: 31256744

9

Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma.

Bas O, Ozbek A, Guven D, Aktepe O, Kılıc L, Kertmen N, Erman M. Bas O, et al. J Oncol Pharm Pract. 2020 Jul;26(5):1230-1233. doi: 10.1177/1078155219884113. Epub 2019 Nov 17. J Oncol Pharm Pract. 2020. PMID: 31735133

10

Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications.

Guven DC, Aktas BY, Simsek C, Aksoy S. Guven DC, et al. Future Oncol. 2020 Mar;16(9):497-506. doi: 10.2217/fon-2019-0783. Epub 2020 Feb 26. Future Oncol. 2020. PMID: 32100550 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters